Tozaro secures Canada-UK Research & Development funding todevelop tools for lentiviral production, in partnership with ViricaBiotech Inc. and Centre for Process Innovation (CPI)
By M T
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing
By Keli
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
By Keli
Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced the appointment of Dr. Jason Slingsby MBA as Chief Executive Officer, effective 22 April 2025.
MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification
By Keli
Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy space
By celf_admin
Tozaro (formally MIP Discovery) secures significant funding to support development of global rapid response diagnostics
By celf_admin
